China: Guidelines for the Enforcement of Medical Aesthetic Advertising

Medical Aesthetic Advertising Beauty Cosmetics Products

On 1st November 2021, the State Administration for Market Regulation of China published the “Guidelines for the Enforcement of Medical Aesthetic Advertising”. These clarify the definition of medical aesthetic and medical aesthetic advertising.

Medical aesthetic advertising belongs to the medical device advertising field. Only advertisers with a medical institution’s practice license can publish or commission medical beauty advertisements.

Demand for plastic surgery or medical aesthetic treatment has boomed in China in recent years, so the aim of this guideline is to warn people about its risks.

Contact RegASK to get prepared for potential regulatory changes in China. Get in touch with RegASK’s experts.

 

Contact RegASK for more details Read more

Have a
regulatory affairs
challenge?

Regulatory Affair Icon